"Lung Diseases, Fungal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pulmonary diseases caused by fungal infections, usually through hematogenous spread.
|Lung Diseases, Fungal
- Lung Diseases, Fungal
- Fungal Lung Disease
- Lung Disease, Fungal
- Pulmonary Fungal Diseases
- Fungal Disease, Pulmonary
- Fungal Diseases, Pulmonary
- Pulmonary Fungal Disease
- Pulmonary Fungal Infections
- Fungal Infection, Pulmonary
- Fungal Infections, Pulmonary
- Pulmonary Fungal Infection
- Fungal Lung Diseases
Below are MeSH descriptors whose meaning is more general than "Lung Diseases, Fungal".
Below are MeSH descriptors whose meaning is more specific than "Lung Diseases, Fungal".
This graph shows the total number of publications written about "Lung Diseases, Fungal" by people in this website by year, and whether "Lung Diseases, Fungal" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Lung Diseases, Fungal" by people in Profiles.
IFN-? immune priming of macrophages in vivo induces prolonged STAT1 binding and protection against Cryptococcus neoformans. PLoS Pathog. 2018 10; 14(10):e1007358.
Dectin-3 Is Not Required for Protection against Cryptococcus neoformans Infection. PLoS One. 2017; 12(1):e0169347.
STAT1 signaling within macrophages is required for antifungal activity against Cryptococcus neoformans. Infect Immun. 2015 Dec; 83(12):4513-27.
STAT1 signaling is essential for protection against Cryptococcus neoformans infection in mice. J Immunol. 2014 Oct 15; 193(8):4060-71.
Depletion of neutrophils in a protective model of pulmonary cryptococcosis results in increased IL-17A production by ?d T cells. BMC Immunol. 2012 Dec 07; 13:65.
Protective immunity against pulmonary cryptococcosis is associated with STAT1-mediated classical macrophage activation. J Immunol. 2012 Oct 15; 189(8):4060-8.
Protective immunity against experimental pulmonary cryptococcosis in T cell-depleted mice. Clin Vaccine Immunol. 2011 May; 18(5):717-23.
Role of IL-17A on resolution of pulmonary C. neoformans infection. PLoS One. 2011 Feb 17; 6(2):e17204.
Interleukin-17 is not required for classical macrophage activation in a pulmonary mouse model of Cryptococcus neoformans infection. Infect Immun. 2010 Dec; 78(12):5341-51.
Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis. PLoS One. 2009 Sep 03; 4(9):e6854.